FIG 2.

Single-round HIV infection of primary human cells with VSVg-pseudotyped virus was inhibited by romidepsin. (A) Schematic representation of the experimental approach. (B) Representative flow cytometry data highlight the reduced infection that results from romidepsin treatment. The percentages of infected, eGFP-positive cells are presented with each dot plot. (C) Compiled data for PBMCs and for CD4⁺ T cells from four human donors are shown (means ± the standard errors of the mean). **, P < 0.01; ***, P < 0.001.